UAB "Via pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
114,039 |
38,013 |
10,310 |
8,763 |
2,921 |
51.84 |
7.68 |
95,163 |
79,973 |
221 |
174,915 |
2023 |
---|
49,866 |
14,975 |
-19,824 |
-19,824 |
-5,953 |
37.54 |
-39.75 |
75,338 |
60,661 |
1 |
135,998 |
2024 |
---|
75,983 |
18,996 |
-51,473 |
-51,473 |
-12,868 |
-11.79 |
-67.74 |
23,865 |
62,021 |
1 |
85,885 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
75,983 €52 % *
Sales per employee (€)
18,996 €27 % *
Profit before tax (€)
-51,473 €-160 % *
Net Profit (€)
-51,473 €-160 % *
Profit per employee (€)
-12,868 €-116 % *
Total profitability (%)
-11.79 %-131.41 % *
Net profitability (%)
-67.74 %-70.42 % *
Equity (€)
23,865 €-68 % *
Amounts Payable And Liabilities (€)
62,021 €2 % *
Non-current Assets (€)
1 €0 % *
CurrentAssets (€)
85,885 €-37 % *